Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Rockefeller
Sloan Kettering
Tri-Institutional MD-PhD Program
Explore this Website
Home
About Us
Toggle About Us menu options
Welcome from Dr. Katharine Hsu
Welcome from Tri-I Students
Leadership and Staff
Our Institutions
Contact Us
Getting to the Tri-Institutional Campus
Admissions
Toggle Admissions menu options
Transfer Policy
Admissions FAQs
Financial Support
Finance FAQs
Curriculum and Community
Toggle Curriculum and Community menu options
Program at a Glance
MD-PhD Specific Courses and Seminars
Tri-I Faculty
Our Students
Toggle Our Students menu options
Student Directory
Diversity and Inclusion
MD-PhD Student Groups
Toggle MD-PhD Student Groups menu options
LGBTQ+ at Tri-I
MD-PhD Houses
Student Housing
Life in New York City
Program FAQ
Tri-I Outcomes
Toggle Tri-I Outcomes menu options
Fellowships and Awards
Student Publications
Thesis Defenses
Residency Matches
Academic Career Progression
Career Paths of Our Alumni
Summer Program
Toggle Summer Program menu options
About the Gateways Program
Gateways Admissions
Gateways To The Laboratory Summer Program FAQ
News and Events
Toggle News and Events menu options
Events Calendar
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Admissions
Curriculum and Community
Tri-I Outcomes
Summer Program
News and Events
Home
Biblio
Found 2 results
Filters:
Keyword
is
Half-Life
[Clear All Filters]
2017
K Min C, Lasseter KC, Marbury TC, Wrishko RE, Hanley WD, Wolford DG, de Haes JUdo, Reitmann C, Gutstein DE
. 2017.
Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
.
.
Int J Clin Pharmacol Ther. 55(9):746-752.
2015
Zhu EF, Gai SA, Opel CF, Kwan BH, Surana R, Mihm MC, Kauke MJ, Moynihan KD, Angelini A, Williams RT et al.
. 2015.
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.
.
Cancer Cell. 27(4):489-501.